ArticleThe oncologist2020

AR-V7 as a Biomarker for Resistance to Treatment with Abiraterone/Enzalutamide in Three Latin American Countries: A Hypothetical Cost-Saving Analysis.

Rafael Adrián Pacheco-Orozco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.